US prenatal genetic test maker Ariosa Diagnostics has won its bid to appeal a ruling that its Harmony test infringed a patent owned by rival Sequenom.
James Cook University has followed through on its promise to appeal a $1.2 million judgment awarded against it for the unfair dismissal of physics professor and climate skeptic Peter Ridd.
The family of an Australian national who was killed aboard Malaysia Airlines flight MH17 is challenging a ruling that blocked it from participating in a recent class action settlement.
Labour hire company Workpac is seeking to stay two class actions over leave entitlements allegedly owed coal miners, amid a looming judgment from the Full Federal Court that will clarify the definition of casual employees.
Two Australian companies have won their application for special leave to the High Court as they continue their fight to shut down a wrongful death case in the US brought by the families of 15 people killed in an aircraft crash near Lockhart River in northern Queensland in May 2005.
The Federal Government wants the High Court to weigh in on a landmark ruling last month that found food manufacturing giant Mondelez was short-changing its Tasmanian shift workers on their personal leave entitlements under the Fair Work Act.
The lead applicant in a class action by passengers of Scenic Tours luxury European river cruises who were forced to take the bus has partially won a bid for the High Court to hear an appeal of a mixed ruling on liability in the case.
The High Court has cleared the way for victims of a rubbish tip fire that tore through 17,000 acres of farmland in the NSW Riverina to claim more than $20 million in damages in a class action, after rejecting an appeal bid by the local council.
A five-judge panel of the Full Federal Court has found two innovation patents by financial software company Encompass Corp. are not a manner of manufacture, but held back on providing more clarity on the test for the patentability of computer-implemented inventions.
Otsuka Pharmaceuticals and Bristol Myers-Squibb are seeking to withdraw admissions in patent litigation against Generic Health over anti-psychotic drug Abilify, following a landmark ruling last year against Wyeth that clarified the issue of compensation under the usual undertaking for damages in pharmaceutical patent cases.